arctigenin has been researched along with gemcitabine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhamed, S; Athikomkulchai, S; Awale, S; Miyatake, R; Saiki, I; Ueda, JY; Yokoyama, S | 1 |
| Abdelhamed, S; Athikomkulchai, S; Awale, S; Dibwe, DF; Miyatake, R; Saiki, I; Ueda, JY; Yokoyama, S | 1 |
| Awale, S; Shakya, B; Ueda, JY; Yadav, PN | 1 |
| Awale, S; Do, TN; Esumi, H; Le, TH; Nguyen, HX; Nguyen, MT; Nguyen, NT | 1 |
| Cui, W; Li, JX; Liu, CX; Shen, Q; Wang, J; Wang, Y; Wu, J; Zhang, L; Zhang, YC | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Saif, MW; Strimpakos, AS | 1 |
| Esumi, H; Fujioka, R; Ikeda, M; Kishino, S; Mochizuki, N; Nomura, S; Owada, S; Sato, A; Tsuchihara, K; Yomoda, S | 1 |
1 trial(s) available for arctigenin and gemcitabine
| Article | Year |
|---|---|
Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with gemcitabine-refractory pancreatic cancer.
Topics: Antineoplastic Agents, Phytogenic; Arctium; Area Under Curve; Biomarkers; Carcinoma, Adenosquamous; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Furans; Gemcitabine; Gluconeogenesis; Humans; Kaplan-Meier Estimate; Kidney; Lactic Acid; Lignans; Liver; Mitochondria; Oxidative Phosphorylation; Pancreatic Neoplasms; Plant Extracts | 2018 |
7 other study(ies) available for arctigenin and gemcitabine
| Article | Year |
|---|---|
Antiausterity agents from Uvaria dac and their preferential cytotoxic activity against human pancreatic cancer cell lines in a nutrient-deprived condition.
Topics: Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Crystallography, X-Ray; Cyclohexenes; Drug Screening Assays, Antitumor; Humans; Nuclear Magnetic Resonance, Biomolecular; Pancreatic Neoplasms; Thailand; Uvaria | 2012 |
Uvaridacols E-H, highly oxygenated antiausterity agents from Uvaria dac.
Topics: Antineoplastic Agents, Phytogenic; Cyclohexenes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pancreatic Neoplasms; Plant Stems; Thailand; Uvaria | 2012 |
Discovery of 2-pyridineformamide thiosemicarbazones as potent antiausterity agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Formamides; Humans; Pancreatic Neoplasms; Pyridines; Thiosemicarbazones | 2014 |
Chemical Constituents of Mangifera indica and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line.
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Mangifera; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pancreatic Neoplasms; Plant Bark; Triterpenes; Vietnam | 2016 |
Synthesis and evaluation of tetrahydroquinolin-2(1H)-one derivatives as novel anti-pancreatic cancer agents via targeting autophagy.
Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Male; Mice, Nude; Pancreas; Pancreatic Neoplasms; Quinolines | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Update on phase I studies in advanced pancreatic adenocarcinoma. Hunting in darkness?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Deoxycytidine; Furans; Gemcitabine; Humans; Hyaluronoglucosaminidase; Lignans; Mutation; Pancreatic Neoplasms; Polyethylene Glycols; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Recombinant Proteins; RNA Interference; Treatment Outcome | 2013 |